The Patent Finder

Oy Juvantia Pharma Ltd.

Also on record
Records under this name other than patents Oy Juvantia Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Oy Juvantia Pharma Ltd.

PatentTitleStatus Expires Confidence
US 8,653,122Oromucosal formulation and process for preparing the same
Formerly held
Lapsed on the fee record
Ended Feb 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2022From the USPTO record
US 7,223,871Process for preparing substituted imidazole derivatives and intermediates used in the process
Lapsed on the fee record
Ended May 29, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 29, 2015From the USPTO record
US 7,741,362Somatostatin receptor 1 and/or 4 selective agonists and antagonists
Formerly held
Lapsed on the fee record
Ended Jun 22, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 22, 2014From the USPTO record
US 6,521,632Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor
Lapsed on the fee record
Ended Feb 18, 2011 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2011From the USPTO record
US 6,124,256Method for the prevention of a patient's fibroproliferative vasculopathy
Lapsed on the fee record
Ended Sep 26, 2008 · From the USPTO record
Lapsed on the fee recordEnded Sep 26, 2008From the USPTO record
US 6,767,909Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
Lapsed on the fee record
Ended Jul 27, 2008 · From the USPTO record
Lapsed on the fee recordEnded Jul 27, 2008From the USPTO record
US 6,696,556DNA molecule encoding a variant &agr;2B-adrenoceptor protein, and uses thereof
Lapsed on the fee record
Ended Feb 24, 2008 · From the USPTO record
Lapsed on the fee recordEnded Feb 24, 2008From the USPTO record
US 6,593,324Dervatives of quinoline as alpha-2 antagonists
Lapsed on the fee record
Ended Jul 15, 2007 · From the USPTO record
Lapsed on the fee recordEnded Jul 15, 2007From the USPTO record
US 5,902,807Method for the treatment of mental illness in mammals and a composition therefor
Formerly held
Term ended
Term ended no later than May 11, 2019 · Low confidence
Term endedTerm ended no later than May 11, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited